Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20030195530 A1
Publication typeApplication
Application numberUS 10/419,412
Publication dateOct 16, 2003
Filing dateApr 21, 2003
Priority dateApr 26, 2000
Also published asCA2365657A1, DE60225494D1, DE60225494T2, DE60239647D1, EP1222897A2, EP1222897A3, EP1222897B1, EP1955661A2, EP1955661A3, EP1955661B1, US6551344, US20010037129
Publication number10419412, 419412, US 2003/0195530 A1, US 2003/195530 A1, US 20030195530 A1, US 20030195530A1, US 2003195530 A1, US 2003195530A1, US-A1-20030195530, US-A1-2003195530, US2003/0195530A1, US2003/195530A1, US20030195530 A1, US20030195530A1, US2003195530 A1, US2003195530A1
InventorsGary Thill
Original AssigneeMicrovena Corporation, A Minnesota Corporation, And Into Ev3 Inc., A Delaware Corpora
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Septal defect occluder
US 20030195530 A1
Abstract
A septal defect occluder is provided having first and second occluder panels. Each occluder panel includes a fabric support structure and fabric suspended therefrom. The occluder panels are conjoined at a plurality of discrete points which are located within an area bounded by each perimeter of the fabric support structures, as well as on the fabric, to thereby form a defect conforming region for the occluder. In an alternate embodiment, each occluder panel includes a cambered fabric support structure and fabric suspended from a perimeter thereof, the occluder panels being arranged in cooperative cambered opposition such that the perimeters of the cambered fabric support structures impart a clamping force upon tissue adjacent a tissue defect interposed there between when the occluder is deployed for tissue defect occlusion.
Images(10)
Previous page
Next page
Claims(26)
What is claimed is:
1. A tissue defect occluder comprising first and second occluder panels, each occluder panel including a cambered fabric support structure and fabric suspended from a perimeter of said cambered fabric support structure, said occluder panels being arranged in cooperative cambered opposition such that the perimeters of said cambered fabric support structures impart a clamping force upon tissue adjacent a tissue defect interposed there between when said occluder is deployed for tissue defect occlusion.
2. The occluder of claim 1 wherein the retrieval force into a catheter for said occluder is less than five pounds.
3. The occluder of claim 2 wherein the distance between the perimeter edges of the occluder panels is less than two millimeters post deployment from a catheter.
4. The occluder of claim 3 wherein the camber of said cambered fabric support structure is about 15% of the diameter of said cambered fabric support structure.
5. The occluder of claim 1 wherein said occluder panels are conjoined at a plurality of discrete points to thereby form a defect conforming region.
6. The occluder of claim 5 wherein said discrete conjoined points are located within each of the cambered fabric support structures, as well as on said fabric.
7. The occluder of claim 6 wherein said cambered fabric support structure includes perimeter and traversing segments.
8. The occluder of claim 7 wherein the conjoined points within the cambered fabric support structure comprise loops formed in the traversing segments of each of the cambered fabric support structures, thereby defining internal eyelets for said support structures.
9. The occluder of claim 8 wherein said internal eyelets substantially delimit said defect conforming region.
10. The occluder of claim 9 wherein the fabric of each of said cambered fabric support structures is conjoined at a single location so as to define a center fabric attachment point for said occluder.
11. The occluder of claim 10 wherein the perimeter segments of at least one of said cambered fabric support structures include loops formed therein, thereby defining perimeter eyelets for said support structure, said perimeter eyelets aiding in the symmetrical collapse of said cambered fabric support structure as during reversible retrieval of said occluder into a catheter.
12. The occluder of claim 11 wherein said internal eyelets are symmetrical about said center fabric attachment point.
13. The occluder of claim 12 wherein said fabric comprises a polymeric material.
14. The occluder of claim 13 wherein said polymeric material comprises a polyester knit.
15. The occluder of claim 13 wherein said polymeric material comprises a 20 denier polyester knit.
16. The occluder of claim 15 wherein said occluder panels are substantially round.
17. A septal defect occluder comprising first and second occluder panels, each panel including a cambered fabric support structure and fabric substantially affixed to a perimeter thereof, each of said cambered fabric support structures comprising cooperating cambered frames, the occluder panels being conjoined at internal frame points located within the perimeter of each of said cambered fabric support structures, the fabric of each of said cambered fabric support structures being joined so as to form a center fabric attachment point.
18. The occluder of claim 17 wherein each of said cooperating cambered frames has an axis of maximum dimension and an axis of minimum dimension.
19. The occluder of claim 17 wherein each of said cooperating cambered frames further has a camber axis, said camber axis being in substantial conformity with said axis of minimum dimension.
20. The occluder of claim 19 wherein said cooperating cambered frames are perpendicularly overlaying, the axis of maximum dimension of one frame substantially aligning with the axis of minimum dimension of the other frame.
21. The occluder of claim 20 wherein said internal frame points comprise loops formed in each of said cambered frames, said loops delimiting a minimum frame dimension and thereby defining internal eyelets for each of said cambered fabric support structures.
22. The occluder of claim 21 wherein the frames of one of said cambered fabric support structures comprise loops formed in said frame of one of said fabric support structures, said loops delimiting a maximum frame dimension and thereby defining perimeter eyelets for said cambered fabric support structure.
23. The occluder of claim 22 wherein said perimeter eyelets cooperatively engage means for urging said occluder from a catheter for reversible deployment in and about a septal defect site.
24. The occluder of claim 23 wherein said fabric comprises a polymeric material.
25. The occluder of claim 24 wherein said polymeric material comprises a polyester knit.
26. The occluder of claim 24 wherein said polymeric material comprises a 20 denier polyester knit.
Description
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation-in-part of co-pending application Ser. No. 09/558,717, filed Apr. 26, 2000, for SEPTAL DEFECT OCCLUDER.
  • TECHNICAL FIELD
  • [0002]
    The present invention generally relates to devices for occluding septal defects or shunts in the heart or the vascular system, and particularly provides a low profile septal defect conforming device reversibly deliverable via catheter to a septal defect site.
  • BACKGROUND OF INVENTION
  • [0003]
    The term “septal defect” generally refers to a perforation or other type hole (i.e., a defect) which passes through a thin wall of muscle or other tissue (i.e., a septum) which divides or separates “areas” within the body. Such defects can occur, either congenitally or by acquisition, between chambers of the heart (i.e., atrium or ventricle) or the great vessels (interatrial and interventricular septal defects or patent ductus arteriosus and aortico-pulmonary window respectively), causing shunting of blood through the opening.
  • [0004]
    In the case of the atrium, the presence of a significantly large septal defect can allow blood to shunt across the defect from the left atrium to the right atrium and hence on to the left ventricle, aorta and brain. If the defect is not closed, the risk of stroke is increased.
  • [0005]
    Shunting of blood from the right to the left side can also have negative consequences. This can lead to death due to cardiac failure or hemoptysis.
  • [0006]
    In patients with significant sized ventricular septal defects or patent ductus arteriosus, there is shunting of blood from the high pressure left ventricle or aorta, into the right side chambers and pulmonary arteries which normally have much lower pressures. The torrential increase in flow at a high pressure can lead to cardiac failure and death, apart from the serious long-term complication of high pulmonary pressures which can cause a reversal of the direction of the shunt.
  • [0007]
    Atrial septal defects were initially corrected by open heart surgery which required the surgeon to open the chest of a patient and bypass the heart temporarily (e.g., by means of a cardiopulmonary bypass and moderate hypothermia) The surgeon would then physically cut into the heart and suture small defects closed. In the case of larger defects, a patch of a biologically compatible material would be sewn onto the septum to cover (i.e., “patch”) the defect.
  • [0008]
    In order to avoid the morbidity, mortality and long recovery times associated with open heart surgery, a variety of transcatheter closure techniques have been attempted. In such techniques, an occluding device is delivered through a catheter to the septal defect site. Once the closure device is positioned adjacent the defect, it must be attached to the rest of the septum in a manner which permits it to effectively block the passage of blood through the defect.
  • [0009]
    One such closure device, as illustrated in U.S. Pat. No. 3,874,388 (King et al.), includes a pair of complex mechanical umbrellas, each having a plurality of arms extending radially from a central hub. The hubs of the two umbrellas are mechanically connected to one another and each umbrella includes a fabric covering over the arms, much like a common umbrella. The ends of each arm are provided with barbs which are anchored into the septum to hold the occluder in place. The complex umbrellas prove rather difficult to unfold after passage through a catheter, requiring an array of cables to deploy the arms. This makes proper placement of the device difficult, and the barbs on the arms prevent retraction or repositioning of the device once it is in place. Use of this device has been limited to adult patients because the device requires a large catheter, such as about 23 French (7.3 mm), for delivery.
  • [0010]
    Rashkind proposed a single-umbrella closure device capable of delivery through a 5 mm system which permitted use in children weighing at least about 20 kg. Similar to the King device, this umbrella utilizes barbed hooks on the ends of umbrella arms to ensure attachment to the septum, with the single umbrella being placed on the left side of the atrial septal defect. The barbs prevent disengagement of the device, and poorly centered or seated devices requiring open heart surgery for correction are common.
  • [0011]
    Due to the low success rate of previous devices, a “modified double-umbrella Rashkind occluder” in which the arms of the device are hinged to permit them to fold back against themselves was developed. A more compact collapsed condition and a less intrusive delivery as by an 11 French (3.7 mm) catheter were thereby facilitated. Furthermore, such a “clamshell” occluder did not include barbs at the end of the radial arms of the umbrella, allowing it to be readjusted and retrieved. Typically, this could be accomplished only once, and without subsequent redeployment due to damage or destruction of the device. Although arguably an improvement over heretofore known devices, such a device generally requires a complex loading jig for deployment and remains susceptible to moderately high shunting.
  • [0012]
    Sideris, in U.S. Pat. No. 4,917,089, proposed an occlusion device which combines a single umbrella with a separate anchoring device. Like the previous defect occlusion devices, Sideris' invention utilizes an umbrella with a plurality of radially extending arms. A string connects the arms of this umbrella to a generally rhomboidally shaped anchor which includes an internal wire skeleton and a central, rhomboidally shaped piece of rubber. The string attached to the struts of the umbrella is affixed to the central rubber element of the anchor. The anchor is placed on the opposite side of the septum from the umbrella, and the length of the string limits movement of the occlusion device with respect to the septum. This style of occluder is difficult to deploy, and its overall bulkiness in the heart causes potential clot emboli due to protrusion into the atrial cavities.
  • [0013]
    Kotula et al., U.S. Pat. No. 5,725,552, provides a collapsible device comprising a heat-set woven metal fabric configured as a bell, hourglass, etc. for occluding an abnormal opening in a body organ. The device of Kotula et al. does not adequately “fill” the defect nor fit flat against, or readily conform to, the structures within the heart, thereby increasing the embolization potential with the use of such device.
  • [0014]
    Das, U.S. Pat. No. 5,334,217, teaches a non-retrievable occluder having paired disks, each of which comprises a membrane, and an elastically deformable frame carried about the periphery of each membrane. The disks are joined only at central portions of each membrane, thereby defining a conjoint disk. The Das device is intended to be self-centering within the defect. Since the ability to achieve defect conformity is limited due to the defined conjoint disk structure, residual shunting can occur. Furthermore, with such a device, the conjoint disk cannot uniformly apply and distribute a force to the “second” disk (e.g., as when the second disk follows the first disk into the catheter for purposes of retrieval. As a result, the occluder is caused to contort, resulting in non-symmetrical collapse, and the problems associated therewith.
  • [0015]
    All of the prior art devices described above suffer shortcomings. First, most of these systems (i.e., the occluder and delivery means) are mechanically complex and require a great deal of remote manipulation for deployment or retrieval, if the device is retrievable. This extensive remote manipulation, such as by applying tension to one or more cables in order to deploy the arms of an umbrella or to anchor the device in place, not only increases the difficulty of the procedure, but tends to increase the likelihood that the device will be improperly deployed. This can necessitate retrieval or repositioning so as to effectively occlude the defect in order to minimize the risk of embolization.
  • [0016]
    Second, all of these devices, except for Kotula and Das, essentially teach two separate members joined to each other at a single interface. With such device, when the left atrial member is opened, the central point tends to ride to the lower margin of the defect. Proper centering of the device is quite difficult, and when a self centering device as disclosed by Das is employed, it is at the cost of defect conformity.
  • [0017]
    Third, heretofore many known devices have a geometry which tends to prevent the occluder from remaining flat against, or within, the defect once deployed from a catheter, which is in and of itself problematic, and which is likely to deform the tissue adjacent the tissue defect. A further limitation associated with such devices is that intimate contact between the perimeter of the occluder and the tissue adjacent the tissue defect (e.g., a septal wall), a prerequisite for the formation of a smooth endothelial growth layer in the final stages of healing, is difficult to obtain using heretofore known occluders.
  • [0018]
    Fourth, heretofore many known devices possess retrieval limitations, while others are fully not retrievable.
  • [0019]
    It is desirable, therefore, to provide a simple, collapsible compact closure device which may be delivered through a catheter. It is also highly advantageous to have such a device which can be readily reversibly deployed and retrieved with a minimum of remote manipulation and applied force. Further, a device which is self-centering and self-occluding, particularly one that possesses a defect conforming variable geometry to fill slit-like defects such as a patent foramen ovale, and one that can be released while still being tethered to the delivery mechanism to assure proper placement and function prior to release, would be superior to heretofore known devices. This is particularly true in view of the need to test for shunting of blood around the occluder device with the septal wall in unrestrained motion prior to release.
  • SUMMARY OF THE INVENTION
  • [0020]
    The present invention is a septal defect occluder which has first and second occluder panels. Each occluder panel includes a fabric support structure and fabric suspended from a perimeter thereof. The occluder panels are conjoined at a plurality of points which are located within an area bounded by the perimeter of each fabric support structure, as well as on the fabric, to thereby form a defect conforming region for the occluder.
  • [0021]
    In an alternate embodiment, a septal defect occluder is provided having first and second occluder panels. Each occluder panel includes a cambered fabric support structure and fabric suspended from a perimeter thereof. The occluder panels are arranged in cooperative cambered opposition such that the perimeters of the cambered fabric support structures impart a clamping force upon tissue adjacent a tissue defect interposed there between when the occluder is deployed for tissue defect occlusion.
  • [0022]
    The present invention is thus an improved device over structures known in the prior art. More specific features and advantages obtained in view of those features will become apparent with reference to the drawing figures and DETAILED DESCRIPTION OF THE INVENTION.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0023]
    [0023]FIG. 1 is a side elevational view of the septal defect occluder of the present invention deployed in a septal defect;
  • [0024]
    [0024]FIG. 2 is an end view of an occluder panel of the septal defect occluder of the present invention, particularly illustrating a center fabric attachment point;
  • [0025]
    [0025]FIG. 3 is an end view of the frame members of the device of the subject invention having two pairs of opposing inward eyelets;
  • [0026]
    [0026]FIG. 4 depicts a fabric sheet suitable for use with the invention;
  • [0027]
    [0027]FIG. 5 is an end view of two frame members of FIG. 3 arranged to form a fabric support structure having both internal and perimeter eyelets;
  • [0028]
    [0028]FIG. 6 depicts a first occluder half, corresponding to the fabric support structure of FIG. 5, showing the relationship between the fabric sheet of FIG. 4 and the underlaying support structure;
  • [0029]
    [0029]FIG. 7 depicts a second occluder half, corresponding to the second fabric support structure of FIG. 5, showing the relationship between the fabric sheet of FIG. 4 and the underlaying support structure;
  • [0030]
    [0030]FIG. 8 is an overhead perspective view of an alternate occluder panel;
  • [0031]
    [0031]FIG. 9 is an overhead perspective view of the underlaying cambered fabric support structure of the alternate occluder panel of FIG. 8;
  • [0032]
    [0032]FIG. 10 is an overhead perspective view of a frame member of the cambered fabric support structure being formed using a cambered winding fixture;
  • [0033]
    [0033]FIG. 11 is a side view of the present invention being delivered within a catheter to a septal defect site;
  • [0034]
    [0034]FIG. 12 is a side view of the present invention being initially deployed within the septal defect, the second occluder half having expanded to conform to a portion of the defect;
  • [0035]
    [0035]FIG. 13 is a side view of the present invention deployed within the septal defect while under the control of tension imparting means;
  • [0036]
    [0036]FIG. 14 is a side view of the present invention being initially retrieved into the catheter from the septal defect site, the first occluder half being collapsed for catheter entry; and,
  • [0037]
    [0037]FIG. 15 is a side view of the present invention on its way to complete retrieval into the catheter from the septal defect site.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0038]
    As shown generally in FIG. 1, a septal defect closure device 20 of the invention may be attached to the septum S (e.g., an atrial septum) to effectively conform to and block the defect, without protruding into atrial cavities and the like. As described in detail below, once the closure device 20 is in place, it becomes anchored to the septum and prevents the flow of blood through the atrial septum to the adjoining chambers of the heart. This will permit the heart to operate normally.
  • [0039]
    Referring now to FIGS. 1 and 2, the extremely low profile closure device includes first and second occluder panels 30, 60. Each panel 30, 60 is generally round (e.g., circular, oval, elliptical etc.) so as to facilitate positioning, and minimizes chances of erosion and puncture. Each panel 30, 60 generally comprises a fabric support structure 32, 62 and fabric 33 suspended from a perimeter 34, 64 of the fabric support structures 32, 62. The occluder panels 30, 60 are conjoined at a plurality of discrete points, located or positioned within the bounds of each of the fabric support structures 32, 62 (i.e., within an area bounded by each perimeter 34, 64 of the support structures 32, 62), as well as on the fabric 33 (which will be further explained with reference to FIGS. 2, 7 and 8). A defect conforming region 80 for the occluder 20 is thereby formed. The nature (i.e., structure, relationships there between and function) of the defect conforming region will be detailed herein below, particularly with reference to FIGS. 1, 2 and 9-14. At this point it may be said that the region 80 expandingly conforms to substantially completely and thoroughly satisfy the perimeter of the defect geometry. This stabilizes panels 30, 60 so that complete coverage of the defect from either direction is achieved. The defect is thereby occluded without distortion of the defect.
  • [0040]
    The fabric support structures 32, 62 of the occluder are generally flexible and elastically deformable, and include perimeter and traversing segments 36, 38. Resilient fabric 33 (FIG. 4) is suspended or otherwise affixed to the perimeter segments 36 of the fabric support structures 32, 62. As particularly shown in FIG. 2, the perimeter segments 36 of the fabric support structures 32, 62 extend substantially around the periphery 35 of the fabric 33. The fabric 33 may be formed of a thin, flexible material which can be folded and pulled taut without being damaged. Elastic polymeric materials such as, for example, polyester knit, nylon, polypropylene, polytetrafluoroethylene (e.g., Teflon®), and expanded polytetrafluoroethylene (e.g., GoreTex®), as well as natural fabrics such as silk, are acceptable.
  • [0041]
    To accommodate the need of the fabric support structure to distort when retrieving the occluder 20 into the catheter, excess fabric can be provided. On an area basis relative to the support structure, an excess of fabric in the range, typically, of about 30-35 percent, and up to 50 percent, is sufficient. This range is required for low stretch fabric that otherwise may prevent the support structure from collapsing in a manner suitable to get into the catheter. However, the 20 denier polyester knit is advantageous in that it is of approximately 50% less bulk than known jersey style knit configurations which facilitates the use of smaller delivery catheters, and allows for the occluders to be retrieved into such catheters at forces that are not detrimental to either the catheter or the occluder (e.g., a 40 mm occluder may be pulled into a 12 French catheter using a reasonable peak force of about four pounds). A further advantage is that two complete fabric “patches” may be incorporated, into the closure device (i.e., no need to remove material to reduce bulk), which thereby creates a device having a high reliability of successful closure.
  • [0042]
    The fabric 33 may be attached to their respective support structures 32, 62 by any suitable means. For instance, the fabric 33 may be directly attached to the support structures 32, 62 by means of an adhesive or the like, or the periphery 35 of the fabric 33 may be wrapped about each of the support structures 32, 62 and the peripheral edge attached to the rest of the fabric so as to essentially define a sleeve about each of the support structures 32, 62. In the latter instance, the sleeve may fit the support structure relatively loosely so that the structure may move within the sleeve with respect to the fabric. The peripheral edge of the fabric may be affixed to the rest of the fabric sheet 33 in any suitable fashion such as by sewing. Preferably, though, the periphery of the fabric can be sewn to at least some portion of the perimeter segments 36 of the support structures 32, 62 using polyester, non-adsorbable suture.
  • [0043]
    Referring to FIG. 1, the fabric support members 32, 62 of the occluder panels 30, 60 are shown as being spaced from one another for purposes of the present explanation, but this is not the normal configuration (i.e., static condition) of the panels. In a static, non deployed condition, the fabric support structures of the device take a generally planar form, with the two fabric support structures 32, 62 generally abutting against, or closely proximate, one another.
  • [0044]
    Again referring to FIGS. 1 and 2, the occluder panels 30, 60 are conjoined at a plurality of discrete points, the points being selected to effectively link each of the fabric support structures 32, 62 together, as well as associate each sheet of fabric 33 carried thereby, so as to form the variably configurable defect conforming region 80. With such arrangement, the resilient fabric 33 is not only inherently or indirectly positionable in response to the defect geometry, but also directly responsive vis-a-vis the conjoined support structures 32, 62.
  • [0045]
    The conjoined points within the fabric support structures 32, 62, which responsively link the opposing structures, comprise loops formed in the traversing segments 38 thereof, these loops defining internal eyelets 40 for the structures 32, 62. The internal eyelets 40 of each of the structures 32, 62 are shown as being joined by suture (e.g., polyester, non-absorbable or other suitable material), and to some extent delimit the defect conforming region 80, and serve to center the occluder 20 within the defect. The remaining points of conjointment comprise the union, at a single point, of the fabric of each of the fabric support structures so as to define a generally central fabric attachment point 42. It is important that fabric 33 of each support structure 32, 62 be limitingly controlled via the union, however it is equally important that the fabric 33 remain substantially suspended for expansion during deployment, preferably exclusively about or by its periphery 35.
  • [0046]
    As best seen in FIG. 2, the center attachment point 42 of the occluder 20 is preferably but not exclusively configured as a sutured cross stitch positioned in the center of the fabric 33. Other attachment configurations or geometries are contemplated, to the extent that the center attachment point 42 maintains its functionality, namely that of control of the peripherally supported fabric, and generally contributing to a centering function for the occluder. Preferably the internal eyelets 40 are symmetrically oriented about the center fabric attachment point 42.
  • [0047]
    In addition to internal eyelets 40 which are formed in the traversing segments 38 of each of the fabric support structures 32, 62, the perimeter segments 36 of at least one (i.e., structure 62) of the fabric support structures 32, 62 include loops formed therein, thereby defining perimeter eyelets 44 for that particular support structure 62. As best seen in FIGS. 1 and 8-12, the perimeter eyelets 44 cooperate with urging means 46 carried by and or through a catheter 47 so as to aid in the symmetrical collapse of each of the fabric support structures 32, 62, and the occluder panels 30, 60 thereby, during reversible retrieval of the device 20 into the catheter 47. The perimeter eyelets 44 associated with the “catheter side” occluder panel 60 transmit and distribute deployment and retrieval forces imparted thereupon through the defect conforming region 80 and to the other occluder panel 30. As will subsequently be discussed, the unique configuration of the fabric support structure components, and the relationships there between, provide numerous advantages (for example: symmetrical collapse of the occluder, less peak force for retrieval into a catheter for deployment, and heretofore unsurpassed sealing of narrow slit defects without the distorting effects typically associated with fixed geometry conjoint areas such as circumferential conjoint disks).
  • [0048]
    Referring now to FIGS. 3-7, the fabric support structures comprise cooperating frames 50, each of which preferably resembles a “bowtie,” as best seen in FIG. 3. A more technical description for the frame geometry might be to characterize it as an octagon (i.e., a frame of eight legs or segments), particularly an octagon having a concave, rather than convex, “top” and “bottom” (i.e., ceiling and floor). Put yet another way, the frames resemble elongated hexagons whose long sides are “pinched” towards each other. The frames 50 may be generally characterized as having maximum and minimum dimensions and corresponding axes of maximum and minimum dimension 52, 54. The above frame description is intended to be illustrative, not limiting, with alternating frame geometries satisfying the general characterization being possible.
  • [0049]
    The internal eyelets 40 of the fabric support structures 32, 62 are formed in each of the frames 50 along the axis of minimum dimension 54 (FIG. 3), as illustrated. The resilient internal eyelets 40 are generally disposed between adjacent ends of two legs or frame segments 51, one end of the eyelet being attached to each leg 51. The internal eyelets 40 are shown as laying generally in the same plane as the legs 51 and may extend generally outwardly of the periphery of each of the support structures 32, 62, or may preferably extend inwardly of the periphery of the structures as shown in the figures. As will be later discussed with respect to an alternate occluder panel design, each of the frames 50, 50A of the fabric support structures 32, 62 may be cambered about their minimum dimension (i.e., the internal eyelets 40 do not lay in the same plane as the legs 51, or more specifically, the internal eyelets 40 and perimeter eyelets 44 are not coplanar) so as to, among other things, provide an occluder capable of exerting a clamping force at the perimeter edge of the tissue defect when deployed. The eyelets are desirably formed to function as spring hinges. This will serve to ensure that the occluder panels 30, 60, particularly the catheter side panel 60, elastically return substantially to a plane-defining configuration even after they have been collapsed and delivered through a catheter.
  • [0050]
    Frames 50 of the device have internal eyelets 40, as previously explained. The internal eyelets 40 of one fabric support structure (i.e., 32) mate (i.e., align or register) with those of the other support structure (i.e., 62) so as to thereby conjoin the occluder panels 30, 60 (FIG. 2). The perimeter eyelets 44 of fabric support structure 62 on the other hand are formed in its frames 50A along the axis of maximum dimension 54 (FIG. 3). The perimeter eyelets 44 cooperatively engage urging means 46 so as to enable remote manipulation of the occluder 20 during retrieval.
  • [0051]
    Each fabric support structure 32, 62 comprises perpendicularly overlaying frames, the axis of maximum dimension 52 of one frame 50 or 50A substantially aligning with the axis of minimum dimension 54 of the other frame (FIG. 5). The somewhat oversized fabric 33 is shown in FIG. 6 underlaying the cooperating frames, the periphery thereof being sewn or otherwise affixed to those portions of the frames, which when configured as shown in FIG. 5, form a perimeter 34, 64 for each of the fabric support structures 32, 62. It is again noted that the preferred fabric 33 contributes to an occluder 20 that has complete opposing fabric patches suspended by the fabric support structures 32, 62, which in turn include a frame geometry and arrangement that generally reduce deployment and retrieval forces. In return, fabric and stitch wear and tear and frame “break through” (i.e., separation of the perimeter segments 36 from the fabric 33 upon expansion of the occluders 30, 60) are minimized.
  • [0052]
    Each frame 50 is preferably formed of a single elongate strand of wire W. As best seen in FIG. 3, each of the legs 51 may simply comprise a length of the wire, and the wire may be bent through greater than 360 degrees to define adjacent legs 51 and to form the loops or eyelets 40, 44. The ends of the wire may be attached to each other in any secure fashion, such as by means of a weldment or a suitable biocompatible cementitious material.
  • [0053]
    The frames 50 should be formed of a flexible, elastically deformable material such as a metal, and the wire comprising the frame is formed of a superelastic material. One such material currently known in the art is a near-stoichiometric nickel/titanium alloy, commonly referred to as Nitinol or NiTi. Such superelastic materials may be elastically deformed to a much greater extent than most other materials, yet substantially fully recover their original shape when released. This permits the frame to be deformed sufficiently for insertion into, and passage through, a small-diameter catheter yet automatically elastically return to its initial shape upon exiting the catheter.
  • [0054]
    The frames are preferably manufactured with nitinol wire that can be wound around the pins of a forming die and subjected to heat treatment. Each device consists of four frames, two frames for each support structure. More particularly, each support structure 32, 62 comprises matchingly paired frame styles (i.e., as shown in FIGS. 6 and 7, occluder panel 30 has a pair of frames 50 whereas occluder panel 60 has a pair of frames 50A). All eyelets 40, 44 can be made having generally a 0.030 inch inside diameter, and, as previously noted, be inward facing (i.e., directed toward the center fabric attachment point 42). The wire ends of each frame can be connected with a titanium hypo tube using a compression crimp. The titanium is more ductile than the nitinol, providing a reliable grip with excellent corrosion resistance. Alternately, the preferred shape of the frame may be cut out from a sheet of such superelastic material as a single block, by chemical etching, punching with a suitable punch and die, or any other appropriate forming method.
  • [0055]
    In order to enhance radiopacity so that the frame can be viewed remotely during deployment, the frame may be provided with a radiopaque coating, such as gold or platinum. For instance, the wire W may be plated with a thin layer of gold or platinum. In one particularly useful embodiment, a helically wound length of a thin radiopaque wire (not shown) is placed over the wire W; such core/coil structures are well known in the art. Alternatively, radiopaque marking bands (not shown), which are commercially available, may be employed. By placing one such band on each leg of the frame, a physician can remotely visualize the frame as a plurality of small bands; when the bands are appropriately spaced from one another on a monitor, the physician knows that the frame is properly deployed.
  • [0056]
    Referring now to FIGS. 8 through 10, an alternate embodiment of the occluder panel 30 (FIG. 8) and, more particularly the fabric support structure 37 (FIG. 9), are shown for the defect occluder of the subject invention. Each occluder panel 30 includes a cambered fabric support structure 37 which otherwise conforms with/to the fabric support structure previously disclosed (i.e., the fabric support structure 37 of FIG. 8, and frame member 39 shown being formed in FIG. 10, each have the general end view appearance as the embodiment depicted in FIGS. 2 and 3 respectively, including eyelets which have been omitted from FIGS. 8 through 10 for the sake of clarity). Each of the occluder panels 30 are arranged in cooperative cambered opposition such that the perimeters 41 of the cambered fabric support structures 37 impart a clamping force upon tissue adjacent a tissue defect interposed there between when the occluder is deployed for tissue defect occlusion. Furthermore, because the entire perimeter 35 of the fabric 33 is supported by the cambered fabric support structure 37, and because the occluder panels 30 are urged together at the perimeter edge of the defect due to their arrangement in biased opposition, intimate contact of the occluder with the tissue is assured which is advantageous in supporting endothelial tissue growth during the final stages of healing.
  • [0057]
    The aforementioned occluder panel design substantially improves performance in the area of the occluder “go flat” characteristic. Such “go flat” characteristic (i.e., “flatness”) is specified as the distance between the perimeter edges of the occluder panels after deployment from the catheter. Heretofore known occluders, particularly larger devices (i.e., in excess of about 28 mm across), sometimes have difficulty returning to a “flat” shape (i.e., less than about 2 mm separation between occluder panels or halves) post deployment from a catheter. Force testing of smaller devices utilizing 0.007″ diameter nitinol wire indicated that the return energy of the fabric support structures was far greater than the energy in larger devices utilizing 0.010″ diameter nitinol wire, thereby permitting the fabric support structures to substantially overcome the forces associated with the fabric suspended thereover, and thus lay “flat”. Solution of the “go flat” problem via an increase in frame wire diameter yielded a less than desirable catheter retrieval force, namely a retrieval force in excess of 5 lbs. Occluder panels having a cambered fabric support structure, and alignment of the panels in biased opposition, provide a tissue defect occluder having a preloaded or added energy effect without increasing wire diameter, and thereby increasing catheter retrieval force.
  • [0058]
    Each of the frame members or elements 39 of each of the fabric support structures 37 are cambered about their minimum dimension 43 (i.e., the internal eyelets do not lay in the same plane as the legs, or more specifically, the internal eyelets and perimeter eyelets are not coplanar). Said another way, each frame element 39 has a camber axis 45 which is in substantial conformity with the axis of minimum dimension 43, compare FIGS. 3 and 10. Each cambered fabric support structure 37 comprises perpendicularly overlaying frames 39, the axis of maximum dimension 48 of one frame substantially aligning with the axis of minimum dimension 43 and camber 45 of the other frame. Furthermore, as best seen in FIGS. 8 and 9, the cambered frame members 39 are arranged in forming the cambered fabric support structure 49 such that a support structure apex 49 is formed, the apex 49 being defined as the intersection of camber axis 45 for the cooperating frame members 39. The somewhat oversized fabric 33 indicated by dashed line in FIG. 8, has a periphery 35 sewn or otherwise affixed, as the embodiment illustrated in FIGS. 2, 6, and 7, to those portions of the frame elements 39 which form a perimeter 41 for each of the fabric support structures 37. It is again noted that the preferred fabric carried by the fabric support structures of the subject invention contributes to an occluder that has complete opposing fabric patches suspended by the cambered fabric support structures, which in turn yields a preloaded frame geometry and occluder panel arrangement that generally reduces deployment and retrieval forces while enhancing the stay flat characteristics of the device.
  • [0059]
    Although the cambered frame members which comprise the cambered fabric support structures are manufactured much like the “planar” frames of FIG. 3, namely with nitinol wire that can be wound around the pins 53 of a forming die 55 and subjected to heat treatment, during the winding process, a biasing mandrel (not shown) is used in combination with the forming die 55 to form the cambered frame member 39. Alternately, the forming die 55 itself may be contoured so as to produce a cambered frame as is depicted in FIG. 10.
  • [0060]
    As with the case of the occluder of FIGS. 1 and 2, the occluder panels are conjoined at a plurality of discrete points, the points being selected to effectively link each of the cambered fabric support structures together, as well as associate each sheet of fabric carried thereby, so as to form the variably configurable defect conforming region. With such arrangement, the resilient fabric is not only inherently or indirectly positionable in response to the defect geometry, but also directly responsive vis-a-vis the conjoined support structures.
  • [0061]
    Referring now to FIGS. 11 through 15, the general closure device 20 of the invention (i.e., those embodiments previously described) is shown being deployed to occlude a defect in a septum S. The first panel 60 (i.e., catheter side occluder panel) of the device 20 is positioned on one side of the defect while the second panel 30 is generally disposed on the other side. The frames 50 or 50A of the fabric support structures 32, 62 are elastically biased toward the position shown in FIG. 2. The defect conforming region 80 is positioned within, and expands so as to occlude the defect. Because the support structures 32, 62, vis-a-vis their frames 50 or 50A, are elastically biased toward their deployed configuration, they are biased generally toward one another and engage opposing sides of the septum about the defect. Since there are no compressive forces acting on the frames which might cause them to collapse, this serves to effectively hold the device in place and occlude the defect. The device is further shown in FIGS. 14 and 15 being retrieved from a septal defect site, as might be required in the event of inadvertent initial placement, size mismatch, or otherwise.
  • [0062]
    The fabric sheets 33 are formed of a relatively porous material (FIG. 4). While this may seem to contradict the purpose of the device, blood will tend to coagulate on the latticework provided by the porous material. Blood flow across the defect is usually substantially blocked after minimal time passage. If so desired, the conjoint portion of the device (or the entire device) may be treated with a thrombogenic agent to speed this natural process or may be impregnated with a biocompatible polymeric compound or the like to make it relatively impervious to fluids.
  • [0063]
    The primary purpose of using a porous fabric is to accelerate the process of permanently anchoring the device in place. The support structures hold the fabric tautly and in intimate contact with the surface of the septum S. This intimate contact between the septum and perimeter of the occluder permits ingrowth of collagen and fibrous tissue from the septum into the fabric. Over time, the membrane resting against the septum will become securely anchored to the septal wall and be covered by a layer of endothelial cells.
  • [0064]
    The design of this device is in stark contrast to the septal defect closure devices known in the art. As explained in detail above, prior art devices employ a mechanical umbrella of one design or another. The radially extending arms of the umbrella contact the septum and serve to space all but the peripheral edge of the umbrella away from the septum. Endothelial cells, collagen and fibrous tissue are therefore permitted to grow into only the very periphery of the umbrella. Thus, while a closure device of the invention essentially becomes an integral part of the septum, the complex mechanical structure of prior art devices does not enable as complete integration as the present invention.
  • [0065]
    The mechanical complexity of prior art devices also tends to markedly affect their durability. In the case of atrial or ventricular septal defects, for example, the heart obviously continues to beat after the device is in place. Since beating of the heart is accomplished by flexure of the heart muscles, the septum will flex to some degree with every beat of the heart. The radial arms must therefore flex with the septum with each and every time the heart beat. The number of cycles of this stress-inducing movement produces repeated stresses on the arms, which can eventually lead to mechanical failure and fracture of the arms.
  • [0066]
    When a closure device of the invention is deployed, the tension of the frame of the support structure opens the panel to occlude the defect. Since there are no radial arms to prop open the device, the occurrence of repeated flexion does not occur due to the beating of the heart or pressure differences between the cardiac chamber during the phase of contraction of the heart. To the contrary, any pressure difference would urge a frame and panel against the septum, more firmly occluding the defect. In addition, the superelastic material of the frame tolerates flexural stresses much better than the rigid steel arms of the prior art devices. The present device therefore will continue to flex with the septum without any significant effect on its structural integrity.
  • [0067]
    Although the foregoing has focused on application of the present invention to occlude atrial septal defects, the invention is not limited to occluding such defects. For instance, the instant closure device can be used to treat ventricular septal defects, patent ductus arteriosus, patent foramen ovale (PFO), or any other congenital or acquired orificial or tubular communications between vascular chambers or vessels.
  • [0068]
    While a preferred embodiment of the present invention has been described, it should be understood that various changes, adaptations and modifications may be made therein without departing from the spirit of the invention. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims.
    ATTACHMENT A
    SER. NO. FILING DATE PATENT NO. ISSUE DATE
    2. 09/760,056 Jan. 1, 2001
    3. 09/628,211 Jul. 28, 2000 6,440,152 B1 Aug. 27, 2002
    4. 10/227,773 Aug. 26, 2002
    5. 09/628,212 Jul. 28, 2000
    6. 09/631,482 Aug. 3, 2000
    7. 09/936,248 Sep. 7, 2001
    8. 10/184,327 Jun. 27, 2002
    9. 09/981,769 Oct. 17, 2001
    10. 10/074,740 Feb. 12, 2002
    11. 10/056,588 Jan. 23, 2002
    12. 10/100,686 Mar. 14, 2002
    13. 10/165,803 Jun. 7, 2003
    14. 10/209,797 Jul. 30, 2002
    15. 10/290,426 Nov. 7, 2002
    16. 10/290,392 Nov. 7, 2002
  • Article Five
  • [0069]
    The Agreement of Merger is on file at the following place of business of the Surviving Company: ev3 Inc., 1861 Buerkle Road, White Bear Lake, Minn. 55110.
  • Article Six
  • [0070]
    A copy of the Agreement of Merger will be furnished by the Surviving Company, on request and without cost, to any stockholder of any constituent corporation.
  • Article Seven
  • [0071]
    The aggregate number of shares of stock which the Merging Company has authority to issue is 35,450,000 shares, which consist of 32,500,000 shares of Class A Common Stock, 200,000 shares of Class B Common Stock, 1,600,000 shares of Series A Convertible Preferred Stock, 150,000 shares of Series B Convertible Preferred Stock, 347,755 shares of Series C Convertible Preferred Stock and 652,245 shares of undesignated stock. The par value of each share of capital stock of the Merging Company is 5.01.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2307480 *Jul 8, 1941Jan 5, 1943Ashe John LTelegraph key
US3123136 *Sep 29, 1960Mar 3, 1964 figures
US3166072 *Oct 22, 1962Jan 19, 1965Jr John T SullivanBarbed clips
US3646615 *Jan 26, 1970Mar 7, 1972Richard A NessReinforcing element for muscles
US3716058 *Jul 17, 1970Feb 13, 1973Atlanta Res InstBarbed suture
US3874388 *Feb 12, 1973Apr 1, 1975Ochsner Med Found AltonShunt defect closure system
US3892232 *Sep 24, 1973Jul 1, 1975Alonzo J NeufeldMethod and apparatus for performing percutaneous bone surgery
US4006747 *Apr 23, 1975Feb 8, 1977Ethicon, Inc.Surgical method
US4007743 *Oct 20, 1975Feb 15, 1977American Hospital Supply CorporationOpening mechanism for umbrella-like intravascular shunt defect closure device
US4669473 *Sep 6, 1985Jun 2, 1987Acufex Microsurgical, Inc.Surgical fastener
US4836204 *Jul 6, 1987Jun 6, 1989Landymore Roderick WMethod for effecting closure of a perforation in the septum of the heart
US4895148 *Mar 22, 1989Jan 23, 1990Concept, Inc.Method of joining torn parts of bodily tissue in vivo with a biodegradable tack member
US4917089 *Aug 29, 1988Apr 17, 1990Sideris Eleftherios BButtoned device for the transvenous occlusion of intracardiac defects
US4924865 *May 16, 1988May 15, 1990Concept, Inc.Repair tack for bodily tissue
US4935028 *Dec 28, 1988Jun 19, 1990Drews Robert CCorneal rivet
US5013316 *Mar 26, 1990May 7, 1991Marlowe Goble ESoft tissue anchor system
US5021059 *May 7, 1990Jun 4, 1991Kensey Nash CorporationPlug device with pulley for sealing punctures in tissue and methods of use
US5085661 *Oct 29, 1990Feb 4, 1992Gerald MossSurgical fastener implantation device
US5102421 *Jun 14, 1990Apr 7, 1992Wm. E. Anpach, IIISuture anchor and method of forming
US5108420 *Feb 1, 1991Apr 28, 1992Temple UniversityAperture occlusion device
US5192301 *Sep 3, 1991Mar 9, 1993Nippon Zeon Co., Ltd.Closing plug of a defect for medical use and a closing plug device utilizing it
US5203864 *Apr 5, 1991Apr 20, 1993Phillips Edward HSurgical fastener system
US5284488 *Dec 23, 1992Feb 8, 1994Sideris Eleftherios BAdjustable devices for the occlusion of cardiac defects
US5380334 *May 6, 1993Jan 10, 1995Smith & Nephew Dyonics, Inc.Soft tissue anchors and systems for implantation
US5397331 *Nov 25, 1992Mar 14, 1995Cook IncorporatedSupporting device and apparatus for inserting the device
US5400805 *Sep 24, 1993Mar 28, 1995American Cyanamid CompanySurgical fastener
US5425744 *Apr 18, 1994Jun 20, 1995C. R. Bard, Inc.Occluder for repair of cardiac and vascular defects
US5486193 *May 1, 1995Jan 23, 1996C. R. Bard, Inc.System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US5505735 *Jun 10, 1993Apr 9, 1996Mitek Surgical Products, Inc.Surgical anchor and method for using the same
US5507811 *Nov 15, 1994Apr 16, 1996Nissho CorporationProsthetic device for atrial septal defect repair
US5601571 *May 22, 1995Feb 11, 1997Moss; GeraldSurgical fastener implantation device
US5620461 *Jan 5, 1995Apr 15, 1997Muijs Van De Moer; Wouter M.Sealing device
US5634936 *Feb 6, 1995Jun 3, 1997Scimed Life Systems, Inc.Device for closing a septal defect
US5709707 *Nov 19, 1996Jan 20, 1998Children's Medical Center CorporationSelf-centering umbrella-type septal closure device
US5725552 *May 14, 1996Mar 10, 1998Aga Medical CorporationPercutaneous catheter directed intravascular occlusion devices
US5728116 *Nov 5, 1996Mar 17, 1998Ethicon, Inc.Spiral surgical tack
US5733294 *Feb 28, 1996Mar 31, 1998B. Braun Medical, Inc.Self expanding cardiovascular occlusion device, method of using and method of making the same
US5741297 *Aug 28, 1996Apr 21, 1998Simon; MorrisDaisy occluder and method for septal defect repair
US5855614 *May 7, 1996Jan 5, 1999Heartport, Inc.Method and apparatus for thoracoscopic intracardiac procedures
US5860948 *Oct 2, 1995Jan 19, 1999Scimed Life Systems, Inc.Apparatus and method for tissue defect repair by deposition
US5861003 *Oct 23, 1996Jan 19, 1999The Cleveland Clinic FoundationApparatus and method for occluding a defect or aperture within body surface
US5879366 *Dec 20, 1996Mar 9, 1999W.L. Gore & Associates, Inc.Self-expanding defect closure device and method of making and using
US5893850 *Nov 12, 1996Apr 13, 1999Cachia; Victor V.Bone fixation device
US5902317 *Aug 19, 1997May 11, 1999Nitinol Medical Technologies, Inc.Stent and method and apparatus for forming and delivering the same
US5904703 *Nov 7, 1997May 18, 1999Bard ConnaughtOccluder device formed from an open cell foam material
US6024756 *Dec 22, 1998Feb 15, 2000Scimed Life Systems, Inc.Method of reversibly closing a septal defect
US6059823 *Jul 6, 1998May 9, 2000Scimed Life Systems, Inc.Endovascular apparatus
US6077291 *Nov 26, 1996Jun 20, 2000Regents Of The University Of MinnesotaSeptal defect closure device
US6079414 *May 7, 1996Jun 27, 2000Heartport, Inc.Method for thoracoscopic intracardiac procedures including septal defect
US6080182 *Dec 19, 1997Jun 27, 2000Gore Enterprise Holdings, Inc.Self-expanding defect closure device and method of making and using
US6171329 *Aug 28, 1998Jan 9, 2001Gore Enterprise Holdings, Inc.Self-expanding defect closure device and method of making and using
US6174322 *Jul 31, 1998Jan 16, 2001Cardia, Inc.Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum
US6190400 *Apr 14, 1997Feb 20, 2001Kensey Nash CorporationBlood vessel sealing device and method of sealing an opening in a blood vessel
US6200336 *Jun 2, 1999Mar 13, 2001Cook IncorporatedMultiple-sided intraluminal medical device
US6206895 *Oct 6, 1999Mar 27, 2001Scion Cardio-Vascular, Inc.Suture with toggle and delivery system
US6206907 *May 7, 1999Mar 27, 2001Cardia, Inc.Occlusion device with stranded wire support arms
US6210338 *Nov 29, 1999Apr 3, 2001Aga Medical Corp.Sizing catheter for measuring cardiovascular structures
US6214029 *Apr 26, 2000Apr 10, 2001Microvena CorporationSeptal defect occluder
US6221092 *Mar 30, 1999Apr 24, 2001Nissho CorporationClosure device for transcatheter operations and catheter assembly therefor
US6231561 *Sep 20, 1999May 15, 2001Appriva Medical, Inc.Method and apparatus for closing a body lumen
US6231589 *Mar 22, 1999May 15, 2001Microvena CorporationBody vessel filter
US6238416 *Nov 5, 1999May 29, 2001Eleftherios B. SiderisTranscatheter surgical patch
US6241747 *Oct 18, 1994Jun 5, 2001Quill Medical, Inc.Barbed Bodily tissue connector
US6245079 *Dec 23, 1999Jun 12, 2001Sutura, Inc.Suturing device and method for sealing an opening in a blood vessel or other biological structure
US6334864 *May 17, 2000Jan 1, 2002Aga Medical Corp.Alignment member for delivering a non-symmetric device with a predefined orientation
US6342064 *Dec 22, 1999Jan 29, 2002Nipro CorporationClosure device for transcatheter operation and catheter assembly therefor
US6346074 *Jun 12, 1996Feb 12, 2002Heartport, Inc.Devices for less invasive intracardiac interventions
US6348053 *Mar 30, 2000Feb 19, 2002Triage Medical, Inc.Bone fixation device
US6355052 *Feb 4, 1997Mar 12, 2002Pfm Produkte Fur Die Medizin AktiengesellschaftDevice for closure of body defect openings
US6368339 *May 19, 2000Apr 9, 2002Aga Medical CorporationMethod of forming medical devices: intra-vascular occlusion devices
US6375671 *Apr 17, 2000Apr 23, 2002Nipro CorporationClosure device for transcatheter operations
US6379368 *May 13, 1999Apr 30, 2002Cardia, Inc.Occlusion device with non-thrombogenic properties
US6391048 *Jul 5, 2000May 21, 2002Integrated Vascular Systems, Inc.Integrated vascular device with puncture site closure component and sealant and methods of use
US6537300 *May 30, 2001Mar 25, 2003Scimed Life Systems, Inc.Implantable obstruction device for septal defects
US6551303 *Oct 27, 1999Apr 22, 2003Atritech, Inc.Barrier device for ostium of left atrial appendage
US6551343 *Mar 14, 2000Apr 22, 2003Bionx Implants, OyBioabsorbable surgical fastener for tissue treatment
US6551344 *Jan 12, 2001Apr 22, 2003Ev3 Inc.Septal defect occluder
US6569188 *Jun 18, 2001May 27, 2003Arthrex, Inc.Hex drive bioabsorbable tissue anchor
US6712836 *May 12, 2000Mar 30, 2004St. Jude Medical Atg, Inc.Apparatus and methods for closing septal defects and occluding blood flow
US6719777 *Dec 7, 2000Apr 13, 2004Integrated Vascular Systems, Inc.Closure device and methods for making and using them
US6911037 *Mar 6, 2002Jun 28, 2005Ev3, Inc.Retrievable septal defect closure device
US7377936 *Aug 31, 2004May 27, 2008Ev3, Inc.Retrievable septal defect closure device
US20020034537 *May 3, 2001Mar 21, 2002Brita SchulzeCationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
US20020055767 *Oct 17, 2001May 9, 2002Forde Sean T.Over-the-wire interlock attachment/detachment mechanism
US20020068950 *Jan 23, 2002Jun 6, 2002Corcoran Michael P.Occlusion device with non-thrombogenic properties
US20030023262 *Jul 16, 2002Jan 30, 2003Jeffrey WelchCardiac implant device tether system and method
US20030028213 *Jul 30, 2002Feb 6, 2003Microvena CorporationTissue opening occluder
US20030045893 *Sep 6, 2001Mar 6, 2003Integrated Vascular Systems, Inc.Clip apparatus for closing septal defects and methods of use
US20030050665 *Sep 7, 2001Mar 13, 2003Integrated Vascular Systems, Inc.Needle apparatus for closing septal defects and methods for using such apparatus
US20030055455 *Sep 20, 2001Mar 20, 2003Scimed Life Systems, Inc.Method and apparatus for treating septal defects
US20030093096 *Oct 11, 2002May 15, 2003Mcguckin James F.Vascular closure
US20040073242 *Jun 5, 2003Apr 15, 2004Nmt Medical, Inc.Patent foramen ovale (PFO) closure device with radial and circumferential support
US20040092973 *Sep 11, 2003May 13, 2004Nmt Medical, Inc.Septal puncture device
US20040098121 *Nov 7, 2003May 20, 2004Nmt Medical, Inc.Patent foramen ovale (PFO) closure with magnetic force
US20050033327 *Aug 31, 2004Feb 10, 2005John GainorRetrievable septal defect closure device
US20050119675 *Oct 25, 2004Jun 2, 2005Adams Daniel O.Patent foramen ovale closure system
US20070106327 *Oct 23, 2006May 10, 2007Ev3 Endovascular, Inc.Tissue opening occluder
US20070112382 *Nov 30, 2006May 17, 2007Microvena CorporationTissue opening occluder
US20080058866 *Oct 29, 2007Mar 6, 2008Young Michelle MTissue opening occluder
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7321798Mar 31, 2005Jan 22, 2008Medtronic, Inc.Trans-septal/trans-myocardial ventricular pacing lead
US7445623 *Oct 15, 2003Nov 4, 2008Claude MialheOcclusive device for medical or surgical use
US7648532Jan 3, 2006Jan 19, 2010Septrx, Inc.Tissue distention device and related methods for therapeutic intervention
US7658747Mar 12, 2003Feb 9, 2010Nmt Medical, Inc.Medical device for manipulation of a medical implant
US7666203May 7, 2004Feb 23, 2010Nmt Medical, Inc.Transseptal puncture apparatus
US7678123Jul 14, 2004Mar 16, 2010Nmt Medical, Inc.Tubular patent foramen ovale (PFO) closure device with catch system
US7678132Jun 7, 2006Mar 16, 2010Ovalis, Inc.Systems and methods for treating septal defects
US7686828Jun 7, 2006Mar 30, 2010Ovalis, Inc.Systems and methods for treating septal defects
US7691112Apr 27, 2004Apr 6, 2010Nmt Medical, Inc.Devices, systems, and methods for suturing tissue
US7691128Oct 14, 2005Apr 6, 2010St. Jude Medical, Cardiology Division, Inc.PFO closure devices and related methods of use
US7704268Apr 21, 2005Apr 27, 2010Nmt Medical, Inc.Closure device with hinges
US7717937Aug 8, 2005May 18, 2010St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods and tools, and related methods of use
US7740640May 28, 2004Jun 22, 2010Ovalis, Inc.Clip apparatus for closing septal defects and methods of use
US7766820Oct 24, 2003Aug 3, 2010Nmt Medical, Inc.Expandable sheath tubing
US7780700Feb 4, 2004Aug 24, 2010ev3 Endovascular, IncPatent foramen ovale closure system
US7797056Sep 6, 2006Sep 14, 2010Nmt Medical, Inc.Removable intracardiac RF device
US7842053Mar 30, 2005Nov 30, 2010Nmt Medical, Inc.Double coil occluder
US7846179Sep 1, 2005Dec 7, 2010Ovalis, Inc.Suture-based systems and methods for treating septal defects
US7867250Dec 19, 2002Jan 11, 2011Nmt Medical, Inc.Septal occluder and associated methods
US7871419Mar 2, 2005Jan 18, 2011Nmt Medical, Inc.Delivery/recovery system for septal occluder
US7887562Oct 29, 2007Feb 15, 2011Ev3 Endovascular, Inc.Tissue opening occluder
US7963952Aug 19, 2004Jun 21, 2011Wright Jr John AExpandable sheath tubing
US7967840Oct 10, 2007Jun 28, 2011Nmt Medical, Inc.PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US7976564May 6, 2002Jul 12, 2011St. Jude Medical, Cardiology Division, Inc.PFO closure devices and related methods of use
US7988690Jan 27, 2005Aug 2, 2011W.L. Gore & Associates, Inc.Welding systems useful for closure of cardiac openings
US8029534 *Mar 16, 2009Oct 4, 2011Cook Medical Technologies LlcClosure device with string retractable umbrella
US8070826Dec 11, 2003Dec 6, 2011Ovalis, Inc.Needle apparatus for closing septal defects and methods for using such apparatus
US8157829Jan 5, 2010Apr 17, 2012Pressure Products Medical Supplies, Inc.Transseptal puncture apparatus
US8257389May 4, 2005Sep 4, 2012W.L. Gore & Associates, Inc.Catching mechanisms for tubular septal occluder
US8257394Jan 14, 2005Sep 4, 2012Usgi Medical, Inc.Apparatus and methods for positioning and securing anchors
US8262694Jan 27, 2005Sep 11, 2012W.L. Gore & Associates, Inc.Devices, systems, and methods for closure of cardiac openings
US8277480Mar 20, 2006Oct 2, 2012W.L. Gore & Associates, Inc.Catch member for PFO occluder
US8277482Aug 30, 2011Oct 2, 2012Cook Medical Technologies LlcClosure device with string retractable umbrella and method for closing a body opening with the same
US8292910Jan 5, 2010Oct 23, 2012Pressure Products Medical Supplies, Inc.Transseptal puncture apparatus
US8308760Apr 20, 2005Nov 13, 2012W.L. Gore & Associates, Inc.Delivery systems and methods for PFO closure device with two anchors
US8361110Apr 21, 2005Jan 29, 2013W.L. Gore & Associates, Inc.Heart-shaped PFO closure device
US8361111May 19, 2005Jan 29, 2013W.L. Gore & Associates, Inc.Devices, systems and methods for closure of cardiac openings
US8372112Sep 7, 2004Feb 12, 2013St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods, and related methods of use
US8372113Mar 16, 2006Feb 12, 2013W.L. Gore & Associates, Inc.Curved arm intracardiac occluder
US8382796Nov 25, 2009Feb 26, 2013St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods and related methods of use
US8430907Sep 28, 2012Apr 30, 2013W.L. Gore & Associates, Inc.Catch member for PFO occluder
US8480706Mar 31, 2006Jul 9, 2013W.L. Gore & Associates, Inc.Tubular patent foramen ovale (PFO) closure device with catch system
US8480709Aug 21, 2012Jul 9, 2013W.L. Gore & Associates, Inc.Catching mechanisms for tubular septal occluder
US8551135Mar 28, 2007Oct 8, 2013W.L. Gore & Associates, Inc.Screw catch mechanism for PFO occluder and method of use
US8568431Jan 16, 2011Oct 29, 2013W.L. Gore & Associates, Inc.Delivery/recovery system for septal occluder
US8568447Oct 15, 2012Oct 29, 2013W.L. Gore & Associates, Inc.Delivery systems and methods for PFO closure device with two anchors
US8574264Sep 16, 2006Nov 5, 2013St. Jude Medical, Cardiology Division, Inc.Method for retrieving a closure device
US8579936Jun 21, 2010Nov 12, 2013ProMed, Inc.Centering of delivery devices with respect to a septal defect
US8636765Apr 5, 2013Jan 28, 2014W.L. Gore & Associates, Inc.Catch member for PFO occluder
US8747439Jul 10, 2006Jun 10, 2014P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US8747483Nov 16, 2012Jun 10, 2014ProMed, Inc.Needle apparatus for closing septal defects and methods for using such apparatus
US8753362Sep 18, 2013Jun 17, 2014W.L. Gore & Associates, Inc.Double spiral patent foramen ovale closure clamp
US8758395Jul 19, 2005Jun 24, 2014Septrx, Inc.Embolic filtering method and apparatus
US8758401Sep 30, 2011Jun 24, 2014ProMed, Inc.Systems and methods for treating septal defects
US8758403Jun 28, 2011Jun 24, 2014W.L. Gore & Associates, Inc.PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US8764848Sep 26, 2005Jul 1, 2014W.L. Gore & Associates, Inc.Occluder device double securement system for delivery/recovery of such occluder device
US8777983Mar 28, 2006Jul 15, 2014Terumo Kabushiki KaishaDefect-closure device and delivery apparatus
US8777985Jan 9, 2013Jul 15, 2014St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods and tools, and related methods of use
US8784448Sep 15, 2008Jul 22, 2014W.L. Gore & Associates, Inc.Patent foramen ovale (PFO) closure device with radial and circumferential support
US8795329Aug 15, 2010Aug 5, 2014W.L. Gore & Associates, Inc.Removable intracardiac RF device
US8808329Apr 3, 2012Aug 19, 2014Bonutti Skeletal Innovations LlcApparatus and method for securing a portion of a body
US8814902Jul 31, 2006Aug 26, 2014Bonutti Skeletal Innovations LlcMethod of securing body tissue
US8814947Mar 29, 2007Aug 26, 2014W.L. Gore & Associates, Inc.Deformable flap catch mechanism for occluder device
US8828049Jan 21, 2010Sep 9, 2014W.L. Gore & Associates, Inc.Split ends closure device and methods of use
US8828051Jun 30, 2011Sep 9, 2014Pfm Medical AgLeft atrial appendage occlusion device
US8845699Mar 6, 2012Sep 30, 2014Bonutti Skeletal Innovations LlcMethod of securing tissue
US8870913Mar 27, 2007Oct 28, 2014W.L. Gore & Associates, Inc.Catch system with locking cap for patent foramen ovale (PFO) occluder
US8870916 *Jul 5, 2007Oct 28, 2014USGI Medical, IncLow profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US8945158Sep 30, 2013Feb 3, 2015W.L. Gore & Associates, Inc.Delivery/recovery system for septal occluder
US8992556Mar 23, 2012Mar 31, 2015Pressure Products Medical Supplies, Inc.Transseptal puncture apparatus
US9005242Apr 4, 2008Apr 14, 2015W.L. Gore & Associates, Inc.Septal closure device with centering mechanism
US9017373Dec 9, 2003Apr 28, 2015W.L. Gore & Associates, Inc.Septal closure devices
US9028527Jul 17, 2014May 12, 2015W.L. Gore & Associates, Inc.Patent foramen ovale (PFO) closure device with radial and circumferential support
US9060767Mar 2, 2009Jun 23, 2015P Tech, LlcTissue fastener and methods for using same
US9067362Oct 31, 2007Jun 30, 2015P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US9078630May 17, 2010Jul 14, 2015St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods and tools, and related methods of use
US9084603Nov 12, 2013Jul 21, 2015W.L. Gore & Associates, Inc.Catch members for occluder devices
US9089323Feb 21, 2006Jul 28, 2015P Tech, LlcDevice and method for securing body tissue
US9138562Apr 18, 2008Sep 22, 2015W.L. Gore & Associates, Inc.Flexible catheter system
US9149263Feb 16, 2010Oct 6, 2015W. L. Gore & Associates, Inc.Tubular patent foramen ovale (PFO) closure device with catch system
US9149281Jun 7, 2013Oct 6, 2015P Tech, LlcRobotic system for engaging a fastener with body tissue
US9155544Mar 20, 2002Oct 13, 2015P Tech, LlcRobotic systems and methods
US9173647Feb 21, 2006Nov 3, 2015P Tech, LlcTissue fixation system
US9173650May 31, 2011Nov 3, 2015P Tech, LlcMethods and devices for trauma welding
US9192395May 7, 2013Nov 24, 2015P Tech, LlcRobotic fastening system
US9216014May 13, 2013Dec 22, 2015W.L. Gore & Associates, Inc.Device with biological tissue scaffold for percutaneous closure of an intracardiac defect and methods thereof
US9226828Sep 20, 2013Jan 5, 2016P Tech, LlcDevices and methods for stabilizing tissue and implants
US9241695Mar 25, 2003Jan 26, 2016W.L. Gore & Associates, Inc.Patent foramen ovale (PFO) closure clips
US9259267Sep 6, 2006Feb 16, 2016W.L. Gore & Associates, Inc.Devices and methods for treating cardiac tissue
US9271741Aug 8, 2013Mar 1, 2016P Tech, LlcRobotic ultrasonic energy system
US9271766Nov 11, 2013Mar 1, 2016P Tech, LlcDevices and methods for stabilizing tissue and implants
US9271779Aug 13, 2013Mar 1, 2016P Tech, LlcMethods of using a robotic spine system
US9326759Jul 2, 2013May 3, 2016W.L. Gore & Associates, Inc.Tubular patent foramen ovale (PFO) closure device with catch system
US9402668Dec 4, 2013Aug 2, 2016P Tech, LlcTissue fixation system and method
US9421005Feb 6, 2007Aug 23, 2016P Tech, LlcMethods and devices for intracorporeal bonding of implants with thermal energy
US9439642Feb 24, 2010Sep 13, 2016P Tech, LlcMethods and devices for utilizing bondable materials
US9463012Oct 5, 2005Oct 11, 2016P Tech, LlcApparatus for guiding and positioning an implant
US9474517Mar 31, 2016Oct 25, 2016W. L. Gore & Associates, Inc.Heart occlusion devices
US9486227Jul 25, 2013Nov 8, 2016P Tech, LlcRobotic retractor system
US20020198563 *Aug 26, 2002Dec 26, 2002Microvena CorporationDefect occluder release assembly & method
US20040010287 *Jul 7, 2003Jan 15, 2004Bonutti Peter M.Method and apparatus for securing tissue
US20040181256 *Mar 14, 2003Sep 16, 2004Glaser Erik N.Collet-based delivery system
US20050119675 *Oct 25, 2004Jun 2, 2005Adams Daniel O.Patent foramen ovale closure system
US20060036284 *Oct 14, 2005Feb 16, 2006Velocimed, LlcPFO closure devices and related methods of use
US20060052804 *Oct 15, 2003Mar 9, 2006Claude MialheOcclusive device for medical or surgical use
US20060200199 *Feb 21, 2006Sep 7, 2006Bonutti Peter MDevice and method for securing body tissue
US20060217760 *Mar 16, 2006Sep 28, 2006Widomski David RMulti-strand septal occluder
US20060224224 *Mar 31, 2005Oct 5, 2006Lambert MuhlenbergTrans-septal/trans-myocardial ventricular pacing lead
US20060229623 *Feb 21, 2006Oct 12, 2006Bonutti Peter MTissue fixation system and method
US20060241687 *Mar 16, 2006Oct 26, 2006Glaser Erik NSeptal occluder with pivot arms and articulating joints
US20070016250 *Sep 16, 2006Jan 18, 2007St. Jude Medical, Cardiology Division, Inc.Closure devices, related delivery methods, and related methods of use
US20070112382 *Nov 30, 2006May 17, 2007Microvena CorporationTissue opening occluder
US20070244494 *Apr 18, 2006Oct 18, 2007Downing Stephen WMethods and devices for treating atrial septal defects
US20080009888 *Jul 5, 2007Jan 10, 2008Usgi Medical, Inc.Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US20090082804 *Mar 28, 2006Mar 26, 2009Terumo Kabushiki KaishaDefect-Closure Device and Delivery Apparatus
US20100234878 *Mar 16, 2009Sep 16, 2010Cook IncorporatedClosure device with string retractable umbrella
Classifications
U.S. Classification606/151, 606/157
International ClassificationA61F2/06, A61M1/10, A61B17/08, A61B17/076, A61M37/00, A61F2/02, A61B17/00, A61B17/12
Cooperative ClassificationA61B2017/00592, A61B2017/00247, A61B2017/00597, A61B2017/00575, A61B17/0057, A61B2017/00606, A61B2017/00867, A61B17/076, A61B2017/00623, A61B2018/00392, A61B2017/00526
European ClassificationA61B17/00P
Legal Events
DateCodeEventDescription
Apr 21, 2003ASAssignment
Owner name: EV3 INC., MINNESOTA
Free format text: MERGER;ASSIGNOR:MICROVENA CORPORATION;REEL/FRAME:014004/0919
Effective date: 20020903
Aug 14, 2003ASAssignment
Owner name: KMC ENTERPRISES INC., KANSAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GRUBBA, BILL;REEL/FRAME:013876/0892
Effective date: 20030808
Aug 17, 2006ASAssignment
Owner name: EV3 ENDOVASCULAR, INC., MINNESOTA
Free format text: CHANGE OF NAME;ASSIGNOR:EV3 INC.;REEL/FRAME:018132/0521
Effective date: 20050131